121 related articles for article (PubMed ID: 32391002)
1. Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL-33/ST2 to Alleviate Renal Ischemia-Reperfusion Injury.
Xu L; Xing Z; Yuan J; Han Y; Jiang Z; Han M; Hou X; Xing W; Li Z
Adv Healthc Mater; 2024 May; 13(13):e2303276. PubMed ID: 38335143
[TBL] [Abstract][Full Text] [Related]
2. TREM2 deficiency aggravates renal injury by promoting macrophage apoptosis and polarization via the JAK-STAT pathway in mice.
Cui Y; Chen C; Tang Z; Yuan W; Yue K; Cui P; Qiu X; Zhang H; Li T; Zhu X; Luo J; Sun S; Li Y; Feng C; Peng L; Xie X; Guo Y; Xie Y; Jiang X; Qi Z; Thomson AW; Dai H
Cell Death Dis; 2024 Jun; 15(6):401. PubMed ID: 38849370
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-derived nanovesicles deliver IL-37 to mitigate renal ischemia-reperfusion injury via endothelial cell targeting.
Ma W; Wu D; Long C; Liu J; Xu L; Zhou L; Dou Q; Ge Y; Zhou C; Jia R
J Control Release; 2024 Jun; 370():66-81. PubMed ID: 38631490
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition.
Xu L; Guo J; Moledina DG; Cantley LG
Nat Commun; 2022 Aug; 13(1):4892. PubMed ID: 35986026
[TBL] [Abstract][Full Text] [Related]
5. Myeloid Response to Acute Kidney Injury.
Nash WT; Yee MS; Okusa MD
Nephron; 2023; 147(1):39-43. PubMed ID: 36108596
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell Spatial Transcriptomics Unveils Platelet-Fueled Cycling Macrophages for Kidney Fibrosis.
Liu J; Zheng B; Cui Q; Zhu Y; Chu L; Geng Z; Mao Y; Wan L; Cao X; Xiong Q; Guo F; Yang DC; Hsu SW; Chen CH; Yan X
Adv Sci (Weinh); 2024 Jun; ():e2308505. PubMed ID: 38838052
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Flexibility and Innate Immunity in Renal Ischemia Reperfusion Injury: The Fine Balance Between Adaptive Repair and Tissue Degeneration.
Tammaro A; Kers J; Scantlebery AML; Florquin S
Front Immunol; 2020; 11():1346. PubMed ID: 32733450
[TBL] [Abstract][Full Text] [Related]
8. Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis.
Kim JS; Ko GJ; Kim YG; Lee SY; Lee DY; Jeong KH; Lee SH
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33352837
[TBL] [Abstract][Full Text] [Related]
9. Associations between Cell-Free Mitochondrial DNA and Inflammation, and Their Clinical Implications for Patients on Hemodialysis: A Prospective Multicenter Cohort Study.
Kim K; Jung SW; Cho WH; Moon H; Jeong KH; Kim JS; Lee SH; Ahn SY; Yang DH; Lee HJ; Lee DY; Moon JY; Kim YG
Blood Purif; 2021; 50(2):214-221. PubMed ID: 32862176
[TBL] [Abstract][Full Text] [Related]
10. Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change.
Cho WH; Park SH; Choi SK; Jung SW; Jeong KH; Kim YG; Moon JY; Lim SJ; Sung JY; Jhee JH; Chin HJ; Choi BS; Lee SH
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32806730
[TBL] [Abstract][Full Text] [Related]
11. Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication.
Nery Neto JAO; Yariwake VY; Câmara NOS; Andrade-Oliveira V
Front Pharmacol; 2023; 14():1248757. PubMed ID: 37927592
[TBL] [Abstract][Full Text] [Related]
12. The ratio of alpha-calcitonin gene-related peptide to substance P is associated with the transition of bone metabolic states during aging and healing.
Liu Q; Yu M; Liao M; Ran Z; Tang X; Hu J; Su B; Fu G; Wu Q
J Mol Histol; 2023 Dec; 54(6):689-702. PubMed ID: 37857924
[TBL] [Abstract][Full Text] [Related]
13. Chronic Kidney Disease Has No Impact on Tear Film Substance P Concentration in Type 2 Diabetes.
Asiedu K; Alotaibi S; Krishnan AV; Kwai N; Poynten A; Markoulli M; Dhanapalaratnam R
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760810
[TBL] [Abstract][Full Text] [Related]
14. Involvement of neuronal tachykinin-like receptor at 86C in
Kashio S; Masuda S; Miura M
iScience; 2023 Sep; 26(9):107553. PubMed ID: 37636053
[TBL] [Abstract][Full Text] [Related]
15. Naringenin is a Potential Anabolic Treatment for Bone Loss by Modulating Osteogenesis, Osteoclastogenesis, and Macrophage Polarization.
Zhou X; Zhang Z; Jiang W; Hu M; Meng Y; Li W; Zhou X; Wang C
Front Pharmacol; 2022; 13():872188. PubMed ID: 35586056
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: a protocol for a randomised controlled trial.
Yang Y; Gao J; Wang S; Wang W; Zhu FL; Wang X; Liang S; Feng Z; Lin S; Zhang L; Chen X; Cai G
BMJ Open; 2022 Feb; 12(2):e047622. PubMed ID: 35190406
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound enhances the therapeutic potential of mesenchymal stem cells wrapped in greater omentum for aristolochic acid nephropathy.
Yang Y; Geng X; Chi K; Liu C; Liu R; Chen X; Hong Q; Cai G
Stem Cell Res Ther; 2021 May; 12(1):261. PubMed ID: 33941258
[TBL] [Abstract][Full Text] [Related]
18. Substance P Improves Renal Ischemia Reperfusion Injury Through Modulating Immune Response.
Kim DJ; Moon JY; Kim SM; Seo JW; Lee YH; Jung SW; Kim K; Kim YG; Lim SJ; Lee S; Son Y; Lee SH
Front Immunol; 2020; 11():600. PubMed ID: 32391002
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
